Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Finasteride may be linked to more psychiatric issues than dutasteride, but a definite cause isn't proven.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

5ARI treatment improves hair growth in older men with minimal side effects.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Spironolactone has the most side effects, including serious risks, while eplerenone and finerenone mainly affect the heart, kidneys, and metabolism.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

5α-reductase inhibitors may increase the risk of depression and suicidal thoughts.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Finasteride may increase the risk of suicidality and depression, especially in younger people.